MedPath

A Validation/Interventional Study on Stress Index in Predicting Mechanical Stress in ARDS Patients

Phase 3
Conditions
Respiratory Distress Syndrome, Adult
Registration Number
NCT00465374
Lead Sponsor
University of Turin, Italy
Brief Summary

30% of ARDS patients ventilated according to NIH protocol presents CT scan evidence of hyperinflation. Functional analysis of pressure-time curve (Stress Index=SI) has been shown to identify this condition in experimental settings. We tested the hypothesis that the SI is an accurate predictor of mechanical stress due to overdistention in ARDS patients.

Detailed Description

The study presents two parts : a preliminary validation study and a clinical study.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Age ≥ 18 years
  • Diagnosis of ARDS based on American-European Consensus Conference criteria
Exclusion Criteria
  • >3 days since ARDS criteria were met and mechanical ventilation was started
  • History of ventricular fibrillation or tachyarrhythmia, unstable angina or myocardial infarction within preceding month
  • Pre-existing chronic obstructive pulmonary disease
  • Major chest wall abnormalities
  • Chest tube with persistent air leak
  • Abdominal distension
  • Body mass index >30
  • Pregnancy
  • Known intracranial abnormality
  • Enrollment in another interventional study

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
reduction of pulmonary inflammatory mediators
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Turin, Department of Anesthesia and Intensive Care Medicine

🇮🇹

Turin, Italy

University of Turin, Department of Anesthesia and Intensive Care Medicine
🇮🇹Turin, Italy
V. M. Ranieri, MD
Contact
+390116334001
marco.ranieri@unito.it
P. Terragni, MD
Contact
+390116334002
pierpaolo.terragni@unito.it

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.